The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (8): 1052-1057.doi: 10.3969/j.issn.1006-5725.2024.08.005
• Feature Reports:day surgery anesthesia • Previous Articles Next Articles
Hongya CHEN1,Huijun WANG1,Yue WANG1,Shaofei SU2,Guyan. WANG1()
Received:
2023-07-26
Online:
2024-04-25
Published:
2024-04-19
Contact:
Guyan. WANG
E-mail:guyanwang2006@163.com
CLC Number:
Hongya CHEN,Huijun WANG,Yue WANG,Shaofei SU,Guyan. WANG. Remimazolam versus propofol on quality of recovery after general anesthesia in elders undergoing ocular fundus daytime surgery[J]. The Journal of Practical Medicine, 2024, 40(8): 1052-1057.
Tab.2
Comparison of QoR-15 scores between two groups"
项目 | P组 (n = 55) | R组 (n = 55) | 平均差值 (95% CI) | P 值 |
---|---|---|---|---|
QoR-15评分 | ||||
术前 | 146.2 ± 9.9 | 144.5 ± 9.5 | 1.7(-1.7 ~ 5.0) | 0.295 |
术后24 h | 135.0 ± 10.3 | 133.3 ± 11.1 | 1.7(-3.9 ~ 7.2) | 0.518 |
术后48 h | 136.1 ± 8.9 | 134.8 ± 8.2 | 1.3(-2.5 ~ 5.1) | 0.453 |
术后72 h | 138.5 ± 4.2 | 138.5 ± 4.2 | 0.0(-3.0 ~ 3.0) | 1.000 |
生理舒适度 | ||||
术前 | 47.2 ± 5.2 | 45.7 ± 5.4 | 1.5(-0.9 ~ 3.9) | 0.202 |
术后24 h | 41.8 ± 5.7 | 40.2 ± 6.9 | 1.7(-1.4 ~ 4.8) | 0.257 |
术后48 h | 42.9 ± 4.9 | 40.7 ± 5.1 | 2.2(-0.1 ~ 4.4) | 0.056 |
术后72 h | 43.9 ± 2.0 | 42.9 ± 1.9 | 1.0(-1.6 ~ 3.6) | 0.405 |
生理独立性 | ||||
术前 | 19.5 ± 4.8 | 19.3 ± 4.2 | 0.2(-1.2 ~ 1.5) | 0.787 |
术后24 h | 14.2 ± 4.2 | 14.5 ± 3.9 | -0.3(-3.0 ~ 2.4) | 0.790 |
术后48 h | 14.3 ± 2.2 | 15.2 ± 1.7 | -0.8(-3.3 ~ 1.7) | 0.477 |
术后72 h | 14.7 ± 1.9 | 15.7 ± 1.7 | -1.0(-3.3 ~ 1.3) | 0.346 |
心理支持 | ||||
术前 | 20.0 ± 0.0 | 20.0 ± 0.0 | 0.0(-1.1 ~ 1.1) | 1.000 |
术后24 h | 19.5 ± 0.8 | 19.5 ± 0.8 | 0.0(-1.1 ~ 1.1) | 1.000 |
术后48 h | 19.5 ± 0.8 | 19.5 ± 0.8 | 0.0(-1.1 ~ 1.1) | 1.000 |
术后72 h | 20.0 ± 0.0 | 20.0 ± 0.0 | 0.0(-1.1 ~ 1.1) | 1.000 |
情感 | ||||
术前 | 39.7 ± 0.5 | 39.7 ± 0.5 | 0.0(-0.7 ~ 0.7) | 1.000 |
术后24 h | 39.7 ± 0.8 | 39.6 ± 0.8 | 0.2(-0.9 ~ 1.2) | 0.734 |
术后48 h | 39.6 ± 0.8 | 39.6 ± 0.8 | 0.0(-1.1 ~ 1.1) | 1.000 |
术后72 h | 39.9 ± 0.4 | 39.9 ± 0.4 | 0.0(-0.5 ~ 0.5) | 1.000 |
疼痛 | ||||
术前 | 19.8 ± 0.4 | 19.8 ± 0.4 | 0.0(-0.5 ~ 0.5) | 1.000 |
术后24 h | 19.8 ± 0.4 | 19.7 ± 0.5 | 0.2(-0.4 ~ 0.7) | 0.549 |
术后48 h | 19.8 ± 0.4 | 20.0 ± 0.0 | -0.2(-0.5 ~ 0.2) | 0.341 |
术后72 h | 20.0 ± 0.0 | 19.8 ± 0.4 | 0.2(-0.2 ~ 0.5) | 0.341 |
Tab.4
Comparison of MAP、HR and BIS between two groups"
指标 | 组别 | T0 | T1 | T2 | T3 | T4 | T5 | T6 |
---|---|---|---|---|---|---|---|---|
MAP(mmHg) | P组 | 113.5 ± 8.7 | 82.0 ± 13.4 | 76.5 ± 12.0 | 69.7 ± 11.3 | 100.2 ± 9.8 | 95.8 ± 5.9 | 95.8 ± 6.4 |
R组 | 98.3 ± 4.1 | 92.0 ± 22.0 | 90.3 ± 13.5 | 89.3 ± 11.9 | 106.0 ± 5.4 | 100.3 ± 13.5 | 87.3 ± 14.4 | |
t值 | 0.884 | -0.953 | -1.875 | -2.938 | -1.278 | -0.746 | 1.321 | |
P值 | 0.397 | 0.363 | 0.090 | 0.015 | 0.230 | 0.473 | 0.216 | |
HR(次/min) | P组 | 65.3 ± 10.2 | 73.8 ± 3.1 | 60.8 ± 8.0 | 59.0 ± 6.3 | 59.0 ± 7.9 | 61.0 ± 9.9 | 64.0 ± 9.3 |
R组 | 68.7 ± 14.5 | 69.2 ± 13.2 | 64.0 ± 7.5 | 63.3 ± 9.0 | 66.2 ± 10.2 | 72.2 ± 22.6 | 64.4 ± 9.8 | |
t值 | -0.460 | 0.842 | -0.708 | -0.963 | -1.362 | -1.107 | -0.069 | |
P 值 | 0.655 | 0.420 | 0.495 | 0.358 | 0.203 | 0.294 | 0.946 | |
BIS | P组 | 92.7 ± 7.9 | 65.0 ± 23.5 | 38.8 ± 11.8 | 51.8 ± 6.3 | 87.5 ± 3.8 | ||
R组 | 96.2 ± 1.2 | 74.0 ± 7.2 | 59.0 ± 3.7 | 62.3 ± 3.0 | 82.2 ± 4.5 | |||
t值 | -1.071 | -0.897 | -4.010 | -3.680 | 2.200 | |||
P 值 | 0.309 | 0.391 | 0.002 | 0.004 | 0.052 |
Tab.5
Comparison of remifentanil dosage, fluid dosage, operation time and anesthesia time between two groups x ± s"
项目 | P组(n = 55) | R组(n = 55) | P 值 | |
---|---|---|---|---|
瑞芬用量(μg) | 796.8 ± 238.5 | 681.6 ± 292.8 | 0.785 | 0.455 |
液体入量(mL) | 720.0 ± 189.0 | 670.0 ± 210.9 | 0.395 | 0.703 |
手术时长(min) | 98.3 ± 21.4 | 96.5 ± 25.9 | 0.118 | 0.909 |
麻醉时长(min) | 110.3 ± 25.3 | 112.3 ± 23.1 | -0.128 | 0.902 |
1 |
DOI M, MORITA K, TAKEDA J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial[J]. J Anesth, 2020,34(4):543-553. doi:10.1007/s00540-020-02788-6
doi: 10.1007/s00540-020-02788-6 |
2 |
ZHANG X, LI S, LIU J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial[J]. BMC Anesthesiol, 2021,21(1):156. doi:10.1186/s12871-021-01373-y
doi: 10.1186/s12871-021-01373-y |
3 |
CHEN S H, YUAN T M, ZHANG J, et al. Remimazolamtosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase Ⅲ trial[J]. J Gastroenterol Hepatol, 2021,36(2):474-481. doi:10.1111/jgh.15188
doi: 10.1111/jgh.15188 |
4 |
SONG S W, JANG Y N, YOON M W, et al. Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial[J]. BMC Anesthesiol, 2022,22(1):226. doi:10.1186/s12871-022-01770-x
doi: 10.1186/s12871-022-01770-x |
5 |
WESSELS E, PERRIE H, SCRIBANTE J, et al. Quality of recovery in the perioperative setting: A narrative review[J]. J Clin Anesth, 2022,78:110685. doi:10.1016/j.jclinane.2022.110685
doi: 10.1016/j.jclinane.2022.110685 |
6 |
BU X S, ZHANG J, ZUO Y X. Validation of the Chinese Version of the Quality of Recovery-15 Score and Its Comparison with the Post-Operative Quality Recovery Scale[J]. Patient, 2016,9(3):251-259. doi:10.1007/s40271-015-0148-6
doi: 10.1007/s40271-015-0148-6 |
7 |
JAENSSON M, NILSSON U, DAHLBERG K. Methods and timing in the assessment of postoperative recovery: a scoping review[J]. Br J Anaesth, 2022,129(1):92-103. doi:10.1016/j.bja.2022.04.015
doi: 10.1016/j.bja.2022.04.015 |
8 |
QIU Q, CHOI S W, WONG S S, et al. Effects of intra-operative maintenance of general anaesthesia with propofol on postoperative pain outcomes - a systematic review and meta-analysis[J]. Anaesthesia, 2016,71(10):1222-1233. doi:10.1111/anae.13578
doi: 10.1111/anae.13578 |
9 |
CHEN Y, JIANG S, WU Y. Effect of 2 different anesthesia methods on stress response in neurosurgical patients with hypertension or normal: A prospective clinical trial[J]. Medicine (Baltimore), 2016,95(35):e4769. doi:10.1097/md.0000000000004769
doi: 10.1097/md.0000000000004769 |
10 |
SHIN S W, CHO A R, LEE H J, et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery[J]. Br J Anaesth, 2010,105(5):661-667. doi:10.1093/bja/aeq257
doi: 10.1093/bja/aeq257 |
11 |
王静,高煜茹,蔡钱伟,等. 瑞马唑仑通过调节肺泡巨噬细胞极化减轻脂多糖诱导的急性肺损伤[J]. 实用医学杂志,2023,39(9):1092-1097. doi:10.3969/j.issn.1006-5725.2023.09.005
doi: 10.3969/j.issn.1006-5725.2023.09.005 |
12 |
LIU X, LIN S, ZHONG Y, et al. Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice[J]. Front Pharmacol, 2021,12:739603. doi:10.3389/fphar.2021.739603
doi: 10.3389/fphar.2021.739603 |
13 |
SHI M, CHEN J, LIU T, et al. Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis[J]. Drug Des Devel Ther, 2022,16:413-423. doi:10.2147/dddt.s344240
doi: 10.2147/dddt.s344240 |
14 |
FANG H, ZHANG Y, WANG J, et al. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages[J]. Int Immunopharmacol, 2021,101(Pt B):108331. doi:10.1016/j.intimp.2021.108331
doi: 10.1016/j.intimp.2021.108331 |
15 |
BEVANS T, DEERING-RICE C, STOCKMANN C, et al. Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents[J]. Anesth Analg, 2017,124(5):1484-1490. doi:10.1213/ane.0000000000002022
doi: 10.1213/ane.0000000000002022 |
16 |
XIE H, LU F, LIU W, et al. Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy[J]. J Pharm Pharmacol, 2021,73(12):1643-1651. doi:10.1093/jpp/rgab080
doi: 10.1093/jpp/rgab080 |
17 |
HARI Y, SATOMI S, MURAKAMI C, et al. Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery[J]. J Anesth, 2022,36(2):265-269. doi:10.1007/s00540-022-03041-y
doi: 10.1007/s00540-022-03041-y |
18 |
CHOI J Y, LEE H S, KIM J Y, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial[J]. J Clin Anesth, 2022,82:110955. doi:10.1016/j.jclinane.2022.110955
doi: 10.1016/j.jclinane.2022.110955 |
19 |
MAO Y, GUO J, YUAN J, et al. Quality of Recovery After General Anesthesia with Remimazolam in Patients' Undergoing Urologic Surgery: A Randomized Controlled Trial Comparing Remimazolam with Propofol[J]. Drug Des Devel Ther, 2022,16:1199-1209. doi:10.2147/dddt.s359496
doi: 10.2147/dddt.s359496 |
20 |
BUCHANAN F F, MYLES P S, CICUTTINI F. Effect of patient sex on general anaesthesia and recovery[J]. Br J Anaesth, 2011,106(6):832-839. doi:10.1093/bja/aer094
doi: 10.1093/bja/aer094 |
21 |
STARK P A, MYLES P S, BURKE J A. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15[J]. Anesthesiology, 2013,118(6):1332-1340. doi:10.1097/aln.0b013e318289b84b
doi: 10.1097/aln.0b013e318289b84b |
22 |
YANG J J, LEI L, QIU D, et al. Effect of Remimazolam on Postoperative Delirium in Older Adult Patients Undergoing Orthopedic Surgery: A Prospective Randomized Controlled Clinical Trial[J]. Drug Des Devel Ther, 2023,17:143-153. doi:10.2147/dddt.s392569
doi: 10.2147/dddt.s392569 |
23 |
DOI M, MORITA K, TAKEDA J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase Ⅱb/Ⅲtrial[J]. J Anesth, 2020,34(4):543-553. doi:10.1007/s00540-020-02788-6
doi: 10.1007/s00540-020-02788-6 |
24 |
DAI G, PEI L, DUAN F, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia[J]. Minerva Anestesiol, 2021,87(10):1073-1079. doi:10.23736/s0375-9393.21.15517-8
doi: 10.23736/s0375-9393.21.15517-8 |
25 | 王惠军, 熊军, 包音,等. 瑞马唑仑用于五官科手术患者喉罩全身麻醉的效果[J]. 中国医药导报,2022,19(24):115-118, 123. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||